IRIS Accounts Production v23.4.0.336 09064960 director 1.7.22 30.6.23 30.6.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh090649602022-06-30090649602023-06-30090649602022-07-012023-06-30090649602021-06-30090649602021-07-012022-06-30090649602022-06-3009064960ns15:EnglandWales2022-07-012023-06-3009064960ns14:PoundSterling2022-07-012023-06-3009064960ns10:Director12022-07-012023-06-3009064960ns10:PrivateLimitedCompanyLtd2022-07-012023-06-3009064960ns10:SmallEntities2022-07-012023-06-3009064960ns10:AuditExempt-NoAccountantsReport2022-07-012023-06-3009064960ns10:SmallCompaniesRegimeForDirectorsReport2022-07-012023-06-3009064960ns10:SmallCompaniesRegimeForAccounts2022-07-012023-06-3009064960ns10:FullAccounts2022-07-012023-06-3009064960ns10:CompanySecretary12022-07-012023-06-3009064960ns10:RegisteredOffice2022-07-012023-06-3009064960ns5:CurrentFinancialInstruments2023-06-3009064960ns5:CurrentFinancialInstruments2022-06-3009064960ns5:ShareCapital2023-06-3009064960ns5:ShareCapital2022-06-3009064960ns5:RetainedEarningsAccumulatedLosses2023-06-3009064960ns5:RetainedEarningsAccumulatedLosses2022-06-3009064960ns5:ComputerEquipment2022-07-012023-06-3009064960ns5:FurnitureFittings2022-06-3009064960ns5:ComputerEquipment2022-06-3009064960ns5:FurnitureFittings2022-07-012023-06-3009064960ns5:FurnitureFittings2023-06-3009064960ns5:ComputerEquipment2023-06-3009064960ns5:FurnitureFittings2022-06-3009064960ns5:ComputerEquipment2022-06-3009064960ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-06-3009064960ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-06-30
REGISTERED NUMBER: 09064960 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2023

FOR

G&SS MEDICAL LTD

G&SS MEDICAL LTD (REGISTERED NUMBER: 09064960)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 30 June 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


G&SS MEDICAL LTD

COMPANY INFORMATION
for the Year Ended 30 June 2023







DIRECTOR: Dr G Subramanian





SECRETARY: S H Subramanian





REGISTERED OFFICE: Ivy Cottage
School Lane
Halam
Newark
Nottinghamshire
NG22 8AD





REGISTERED NUMBER: 09064960 (England and Wales)





ACCOUNTANTS: Beeley Hawley & Co. Ltd
Chartered Accountants
42-44 Nottingham Road
Mansfield
Nottinghamshire
NG18 1BL

G&SS MEDICAL LTD (REGISTERED NUMBER: 09064960)

BALANCE SHEET
30 June 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,015 1,899

CURRENT ASSETS
Debtors 5 64,584 43,379
Cash at bank 141,603 130,999
206,187 174,378
CREDITORS
Amounts falling due within one year 6 41,044 40,106
NET CURRENT ASSETS 165,143 134,272
TOTAL ASSETS LESS CURRENT
LIABILITIES

167,158

136,171

CAPITAL AND RESERVES
Called up share capital 7 7
Retained earnings 167,151 136,164
SHAREHOLDERS' FUNDS 167,158 136,171

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 1 March 2024 and were signed by:





Dr G Subramanian - Director


G&SS MEDICAL LTD (REGISTERED NUMBER: 09064960)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 30 June 2023

1. STATUTORY INFORMATION

G&SS Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

G&SS MEDICAL LTD (REGISTERED NUMBER: 09064960)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 June 2023

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 July 2022 1,300 5,535 6,835
Additions - 1,021 1,021
At 30 June 2023 1,300 6,556 7,856
DEPRECIATION
At 1 July 2022 569 4,367 4,936
Charge for year 183 722 905
At 30 June 2023 752 5,089 5,841
NET BOOK VALUE
At 30 June 2023 548 1,467 2,015
At 30 June 2022 731 1,168 1,899

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 64,167 42,962
Other debtors 417 417
64,584 43,379

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Tax 21,420 15,097
Social security and other taxes 316 297
VAT 14,367 12,039
Directors' loan accounts 2,635 10,532
Accrued expenses 2,306 2,141
41,044 40,106